Treatment with the proteasome inhibitor bortezomib, a strong inhibitor of NF-κB signalling pathway, led to downregulation of miR-21 even in MM/BMSCs cocultures [84]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.